ID

30991

Description

Sirolimus in Combination With MEC in High Risk Myeloid Leukemias; ODM derived from: https://clinicaltrials.gov/show/NCT00780104

Lien

https://clinicaltrials.gov/show/NCT00780104

Mots-clés

Versions (1)
  1. 09/07/2018 09/07/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

9 juillet 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Myeloid Leukemias NCT00780104

Anglais

Eligibility Myeloid Leukemias NCT00780104

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
must have histologic evidence of advanced myeloid leukemias defined as one of the following: primary refractory non-m3 aml; relapsed non-m3 aml; secondary aml; intermediate or poor prognosis de novo aml in patients who are >= 60 years old
Description

Myeloid Leukemia Advanced | Refractory Acute Myeloid Leukemia Primary FAB | Recurrent adult acute myeloid leukemia FAB | Secondary acute myeloid leukemia | AML de novo Prognosis Intermediate | AML de novo Prognosis bad | Age

Type de données

boolean

Alias
UMLS CUI [1,1]
C0023470
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C4528668
UMLS CUI [2,2]
C0205225
UMLS CUI [2,3]
C2984084
UMLS CUI [3,1]
C0278780
UMLS CUI [3,2]
C2984084
UMLS CUI [4]
C0280449
UMLS CUI [5,1]
C0023467
UMLS CUI [5,2]
C1515568
UMLS CUI [5,3]
C0033325
UMLS CUI [5,4]
C0205103
UMLS CUI [6,1]
C0023467
UMLS CUI [6,2]
C1515568
UMLS CUI [6,3]
C0278252
UMLS CUI [7]
C0001779
>= 18 years of age
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status of 0, 1
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
able to consume oral medication
Description

Able to swallow Oral medication

Type de données

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0175795
initial laboratory values: creatinine <= 2.0 mg/dl; total or direct bilirubin <= 1.5/dl; sgpt(alt) <= 3xuln; negative pregnancy test for women with child-bearing potential
Description

Laboratory Results Initial | Creatinine measurement, serum | Serum total bilirubin measurement | Bilirubin, direct measurement | Alanine aminotransferase measurement | Childbearing Potential Pregnancy test negative

Type de données

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C0205265
UMLS CUI [2]
C0201976
UMLS CUI [3]
C1278039
UMLS CUI [4]
C0201916
UMLS CUI [5]
C0201836
UMLS CUI [6,1]
C3831118
UMLS CUI [6,2]
C0427780
ejection fraction of >= 45%
Description

Cardiac ejection fraction

Type de données

boolean

Alias
UMLS CUI [1]
C0232174
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects with fam b3
Description

Other Coding

Type de données

boolean

Alias
UMLS CUI [1]
C3846158
must not be receiving chemotherapy (except hydroxyurea)
Description

Chemotherapy | Exception Hydroxyurea

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0020402
not receiving growth factors, except for erythropoietin
Description

Growth Factor | Exception Erythropoietin

Type de données

boolean

Alias
UMLS CUI [1]
C0018284
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0014822
subjects with a "currently active" second malignancy other than non-melanoma skin cancers
Description

Second Cancer | Exception Skin carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0751623
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
subjects with uncontrolled high blood pressure, unstable angina, symptomatic congestive heart failure, mi within the last 6 months or uncontrolled cardiac arrhythmia
Description

Uncontrolled hypertension | Angina, Unstable | Symptomatic congestive heart failure | Myocardial Infarction | Cardiac Arrhythmia Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0742758
UMLS CUI [4]
C0027051
UMLS CUI [5,1]
C0003811
UMLS CUI [5,2]
C0205318
subjects taking diltiazem
Description

Diltiazem

Type de données

boolean

Alias
UMLS CUI [1]
C0012373
subjects who require hiv protease inhibitors or those with aids-related illnesses
Description

Patient need for HIV Protease Inhibitors | AIDS related illness

Type de données

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C0162714
UMLS CUI [2]
C0740842
no evidence of cerebellar dysfunction at baseline or during prior cytarabine therapy
Description

Cerebellar Dysfunction | Cerebellar Dysfunction During Cytarabine Therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0007760
UMLS CUI [2,1]
C0007760
UMLS CUI [2,2]
C0347984
UMLS CUI [2,3]
C0010711
UMLS CUI [2,4]
C0087111
not pregnant or breastfeeding
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
uncontrolled infection
Description

Communicable Disease Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
subjects taking carbamazepine, rifabutin, rifampin, rifapentine, st. john's wort, clarithromycin, cyclosporine, diltiazem, erythromycin, telithromycin, verapamil, tacrolimus
Description

Carbamazepine | Rifabutin | Rifampin | rifapentine | ST. JOHN'S WORT EXTRACT | Clarithromycin | Cyclosporine | Diltiazem | Erythromycin | telithromycin | Verapamil | Tacrolimus

Type de données

boolean

Alias
UMLS CUI [1]
C0006949
UMLS CUI [2]
C0140575
UMLS CUI [3]
C0035608
UMLS CUI [4]
C0073372
UMLS CUI [5]
C0813171
UMLS CUI [6]
C0055856
UMLS CUI [7]
C0010592
UMLS CUI [8]
C0012373
UMLS CUI [9]
C0014806
UMLS CUI [10]
C0907410
UMLS CUI [11]
C0042523
UMLS CUI [12]
C0085149
Retour au début de la page

Similar models

Eligibility Myeloid Leukemias NCT00780104

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Myeloid Leukemia Advanced | Refractory Acute Myeloid Leukemia Primary FAB | Recurrent adult acute myeloid leukemia FAB | Secondary acute myeloid leukemia | AML de novo Prognosis Intermediate | AML de novo Prognosis bad | Age
Item
must have histologic evidence of advanced myeloid leukemias defined as one of the following: primary refractory non-m3 aml; relapsed non-m3 aml; secondary aml; intermediate or poor prognosis de novo aml in patients who are >= 60 years old
boolean
C0023470 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C4528668 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C2984084 (UMLS CUI [2,3])
C0278780 (UMLS CUI [3,1])
C2984084 (UMLS CUI [3,2])
C0280449 (UMLS CUI [4])
C0023467 (UMLS CUI [5,1])
C1515568 (UMLS CUI [5,2])
C0033325 (UMLS CUI [5,3])
C0205103 (UMLS CUI [5,4])
C0023467 (UMLS CUI [6,1])
C1515568 (UMLS CUI [6,2])
C0278252 (UMLS CUI [6,3])
C0001779 (UMLS CUI [7])
Age
Item
>= 18 years of age
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0, 1
boolean
C1520224 (UMLS CUI [1])
Able to swallow Oral medication
Item
able to consume oral medication
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
Laboratory Results Initial | Creatinine measurement, serum | Serum total bilirubin measurement | Bilirubin, direct measurement | Alanine aminotransferase measurement | Childbearing Potential Pregnancy test negative
Item
initial laboratory values: creatinine <= 2.0 mg/dl; total or direct bilirubin <= 1.5/dl; sgpt(alt) <= 3xuln; negative pregnancy test for women with child-bearing potential
boolean
C1254595 (UMLS CUI [1,1])
C0205265 (UMLS CUI [1,2])
C0201976 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0201916 (UMLS CUI [4])
C0201836 (UMLS CUI [5])
C3831118 (UMLS CUI [6,1])
C0427780 (UMLS CUI [6,2])
Cardiac ejection fraction
Item
ejection fraction of >= 45%
boolean
C0232174 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Other Coding
Item
subjects with fam b3
boolean
C3846158 (UMLS CUI [1])
Chemotherapy | Exception Hydroxyurea
Item
must not be receiving chemotherapy (except hydroxyurea)
boolean
C0392920 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0020402 (UMLS CUI [2,2])
Growth Factor | Exception Erythropoietin
Item
not receiving growth factors, except for erythropoietin
boolean
C0018284 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0014822 (UMLS CUI [2,2])
Second Cancer | Exception Skin carcinoma
Item
subjects with a "currently active" second malignancy other than non-melanoma skin cancers
boolean
C0751623 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
Uncontrolled hypertension | Angina, Unstable | Symptomatic congestive heart failure | Myocardial Infarction | Cardiac Arrhythmia Uncontrolled
Item
subjects with uncontrolled high blood pressure, unstable angina, symptomatic congestive heart failure, mi within the last 6 months or uncontrolled cardiac arrhythmia
boolean
C1868885 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0742758 (UMLS CUI [3])
C0027051 (UMLS CUI [4])
C0003811 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
Diltiazem
Item
subjects taking diltiazem
boolean
C0012373 (UMLS CUI [1])
Patient need for HIV Protease Inhibitors | AIDS related illness
Item
subjects who require hiv protease inhibitors or those with aids-related illnesses
boolean
C0686904 (UMLS CUI [1,1])
C0162714 (UMLS CUI [1,2])
C0740842 (UMLS CUI [2])
Cerebellar Dysfunction | Cerebellar Dysfunction During Cytarabine Therapy
Item
no evidence of cerebellar dysfunction at baseline or during prior cytarabine therapy
boolean
C0007760 (UMLS CUI [1])
C0007760 (UMLS CUI [2,1])
C0347984 (UMLS CUI [2,2])
C0010711 (UMLS CUI [2,3])
C0087111 (UMLS CUI [2,4])
Pregnancy | Breast Feeding
Item
not pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Communicable Disease Uncontrolled
Item
uncontrolled infection
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Carbamazepine | Rifabutin | Rifampin | rifapentine | ST. JOHN'S WORT EXTRACT | Clarithromycin | Cyclosporine | Diltiazem | Erythromycin | telithromycin | Verapamil | Tacrolimus
Item
subjects taking carbamazepine, rifabutin, rifampin, rifapentine, st. john's wort, clarithromycin, cyclosporine, diltiazem, erythromycin, telithromycin, verapamil, tacrolimus
boolean
C0006949 (UMLS CUI [1])
C0140575 (UMLS CUI [2])
C0035608 (UMLS CUI [3])
C0073372 (UMLS CUI [4])
C0813171 (UMLS CUI [5])
C0055856 (UMLS CUI [6])
C0010592 (UMLS CUI [7])
C0012373 (UMLS CUI [8])
C0014806 (UMLS CUI [9])
C0907410 (UMLS CUI [10])
C0042523 (UMLS CUI [11])
C0085149 (UMLS CUI [12])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial